Published in Hypertension on December 01, 1990
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol (2005) 2.25
Effect of prolonged administration of a urinary kinase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats. Br J Pharmacol (1999) 0.83
Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Proc Natl Acad Sci U S A (1996) 0.82
Evidence for a major gene influencing 7-year increases in diastolic blood pressure with age. Am J Hum Genet (1995) 0.80
Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability. Br J Pharmacol (1995) 0.75
International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev (2000) 6.30
Atrial natriuretic factor--a circulating hormone stimulated by volume loading. Nature (1985) 4.23
Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension (1992) 3.14
The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J (1992) 2.97
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2007) 2.91
The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest (1995) 2.35
Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol (1985) (1992) 2.24
Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev (1995) 1.91
Biglycan is required for adaptive remodeling after myocardial infarction. Circulation (2008) 1.72
Rearrangement of the oncogene c-mos in mouse myeloma NSI and hybridomas. Nature (1984) 1.66
Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system. J Hypertens (1997) 1.62
Biosynthesis of antinutritional alkaloids in solanaceous crops is mediated by clustered genes. Science (2013) 1.60
Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension (1994) 1.56
Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE. Acta Crystallogr D Biol Crystallogr (2006) 1.56
"Retroposon" insertion into the cellular oncogene c-myc in canine transmissible venereal tumor. Proc Natl Acad Sci U S A (1985) 1.56
AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension (1998) 1.54
The Mdm2 oncoprotein interacts with the cell fate regulator Numb. Mol Cell Biol (1998) 1.53
Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats. Cardiovasc Res (1998) 1.45
Extracorporeal shock wave treatment raises blood pressure in borderline hypertensive rats. J Urol (1995) 1.45
Alpha atrial natriuretic peptide concentrations in plasma of children with congenital heart and pulmonary diseases. Br Med J (Clin Res Ed) (1985) 1.40
Repression of c-fos and c-jun gene expression is not part of AT2 receptor coupled signal transduction. J Mol Med (Berl) (1998) 1.39
Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension (1992) 1.37
Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry (2006) 1.30
Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke (1999) 1.23
Angiotensin synthesis in the brain and increased turnover in hypertensive rats. Science (1983) 1.17
The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. Oncogene (1994) 1.15
Expression of the bcl-2 gene in mouse B lymphocytic cell lines is differentiation stage specific. Eur J Immunol (1987) 1.14
The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol (1996) 1.13
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol (2001) 1.12
Recognition and management of overweight and obesity in primary care in Germany. Int J Obes Relat Metab Disord (2004) 1.09
SPINE bioinformatics and data-management aspects of high-throughput structural biology. Acta Crystallogr D Biol Crystallogr (2006) 1.08
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol (2012) 1.08
High-protein nutrition during pregnancy and lactation programs blood pressure, food efficiency, and body weight of the offspring in a sex-dependent manner. Am J Physiol Regul Integr Comp Physiol (2006) 1.08
AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther (2001) 1.08
Oxytocin unlike vasopressin is a stress hormone in the rat. Neuroendocrinology (1983) 1.07
Effect of repetitive icv injections of ANG II on c-Fos and AT(1)-receptor expression in the rat brain. Am J Physiol Regul Integr Comp Physiol (2001) 1.06
The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers. J Hum Hypertens (2002) 1.06
The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol (1999) 1.05
The angiotensin II type 2 (AT2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med (1998) 1.01
Converting-enzyme in the choroid plexus, brain, and kidney: immunocytochemical and biochemical studies in rats. Neurosci Lett (1981) 1.01
Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension (1995) 1.01
Components of the renin-angiotensin system in the cerebrospinal fluid of rats and dogs with special consideration of the origin and the fate of angiotensin II. Neuroendocrinology (1980) 1.00
Catecholamine excretion in "idiopathic" edema: decreased dopamine excretion, a pathogenic factor? J Clin Endocrinol Metab (1977) 1.00
Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins. Hypertension (1989) 0.98
Expression of autoimmune disease-related antigens by cells of the immune system. J Neurosci Res (1998) 0.98
[Determination of the activity of peptidases and amino acid aryl amidases (author's transl)]. J Clin Chem Clin Biochem (1976) 0.98
Psychiatric sequelae to term birth and induced early and late abortion: a longitudinal study. Fam Plann Perspect (1973) 0.98
Angiotensin peptides and inducible transcription factors. J Mol Med (Berl) (1999) 0.98
Tissue-specific expression of a rat renin transcript lacking the coding sequence for the prefragment and its stimulation by myocardial infarction. Endocrinology (2000) 0.96
Measurement and characterization of angiotensin peptides in plasma. Clin Chem (1988) 0.96
Gabaergic stimulation inhibits central actions of angiotensin II: pressor responses, drinking and release of vasopressin. Eur J Pharmacol (1983) 0.95
Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1985) 0.95
Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept (2001) 0.95
Modulation of autonomic nervous system adjustments to heat stress by central ANG II receptor antagonism. Am J Physiol (1994) 0.95
The intrarenal renin-angiotensin-system. An immunocytochemical study on the localization of renin, angiotensinogen, converting enzyme and the angiotensins in the kidney of mouse and rat. Klin Wochenschr (1982) 0.95
The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol (1997) 0.95
Evidence for the presence of enkephalins in the heart. Life Sci (1983) 0.95
Physiological and pharmacological implications of AT1 versus AT2 receptors. Kidney Int Suppl (1998) 0.95
Differential expression of angiotensin receptors in human cutaneous wound healing. Br J Dermatol (2005) 0.94
Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens (1987) 0.94
Determining the origins and the structural aberrations of small marker chromosomes in two cases of 45,X/46,X, + mar by use of chromosome-specific DNA probes. Am J Med Genet (1990) 0.94
Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves. Brain Res Mol Brain Res (1998) 0.94
Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther (1992) 0.94
Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor. Brain Res Mol Brain Res (1998) 0.93
Role of the kidney in primary hypertension: a renal transplantation study in rats. Am J Physiol (1990) 0.93
Effect of sodium chloride and sodium bicarbonate on blood pressure in stroke-prone spontaneously hypertensive rats. Clin Sci (Lond) (1988) 0.93
Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol (1985) 0.93
Antihypertensive and cardioprotective effects after angiotensin-converting enzyme inhibition: role of kinins. J Card Fail (1997) 0.93
Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol (1995) 0.93
[Aim, design and methods of the "Hypertension and diabetes screening and awareness" -- (HYDRA) study]. Fortschr Med Orig (2003) 0.92
Brain angiotensin: pathways and pharmacology. Circulation (1988) 0.92
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. Br J Pharmacol (1992) 0.92
Converting enzyme inhibition in kinin-deficient brown Norway rats. Hypertension (1990) 0.92
Release and regulation of atrial natriuretic peptide (ANP). Eur Heart J (1987) 0.92
Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone (2013) 0.90
Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. Eur J Pharmacol (1981) 0.90
Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction--effects of AT(1) and AT(2) receptor antagonists and ACE inhibitor. Br J Pharmacol (2001) 0.90
Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. J Pharmacol Exp Ther (1986) 0.90
Angiotensin II induces a complex activation of transcription factors in the rat brain: expression of Fos, Jun and Krox proteins. Neuroscience (1995) 0.90
Enkephalin effects on blood pressure, heart rate, and baroreceptor reflex. Hypertension (1980) 0.90
The tissue renin-angiotensin systems: focus on brain angiotensin, adrenal gland and arterial wall. Clin Exp Hypertens A (1983) 0.89
Decreased cardiac concentration of cGMP kinase in hypertensive animals. An index for cardiac vascularization? Circ Res (1989) 0.89
[Aminoacid-p-nitroanilides splitting activities in the mouse human placenta (author's transl)]. Arch Gynakol (1977) 0.89
Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats. Eur J Pharmacol (1981) 0.89
Positive Association Between Adipose Tissue and Bone Stiffness. Calcif Tissue Int (2015) 0.89
Vasopressin in deoxycorticosterone acetate hypertension of rats: a hemodynamic analysis. J Cardiovasc Pharmacol (1983) 0.89
HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. Eur J Pharmacol (1991) 0.89
Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes (1998) 0.89
Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension (1992) 0.89
Oxytocin pathways mediate the cardiovascular and behavioral responses to substance P in the rat brain. Hypertension (1998) 0.88
Patterns of antihypertensive drug utilization in primary care. Eur J Clin Pharmacol (2004) 0.88
Complex activation of inducible transcription factors in the brain of normotensive and spontaneously hypertensive rats following central angiotensin II administration. Regul Pept (1996) 0.88
Cell surface trafficking of Fas in NIT-1 cells and dissection of surface and total Fas expression. Biochem Biophys Res Commun (2002) 0.88
Angiotensin II receptor blockade and end-organ protection. Am J Hypertens (1999) 0.88
Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy. Am J Cardiol (1997) 0.88
Hypertension transmitted by kidneys from stroke-prone spontaneously hypertensive rats. Am J Physiol (1989) 0.88
Endogenous tissue renin-angiotensin systems. From molecular biology to therapy. Am J Med (1988) 0.88
Regulatory role of vasoactive peptides in subcutaneous skin microcirculation of the hamster. Int J Microcirc Clin Exp (1988) 0.87